Brief: India's Strides Pharma Science Posts Sept-Quarter Consol Net Loss
Oct 30 (Reuters) - Strides Pharma Science Ltd SRID.NS :
* INDIA'S STRIDES PHARMA SCIENCE LTD SEPT-QUARTER CONSOL NET
LOSS
1.31 BILLION RUPEES VERSUS PROFIT 228.3 MILLION RUPEES
* STRIDES PHARMA SCIENCE LTD SEPT-QUARTER CONSOL REVENUE
FROM
OPERATIONS 9.99 BILLION RUPEES VERSUS 8.97 BILLION RUPEES
Source text for Eikon: ID:nBSEcdSc3w
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees